摘要: Within the past years, health services research projects have analyzed critically management of atopic eczema (AE) in routine care, quantified utility controlling severe AE, and introduced an international standardization core outcome measures for AE. With a prevalence 16%, AE is most frequent chronic condition at all among children adolescents seeking medical care. Despite lower adults, about 60% patients with care are adults. There clinically relevant comorbidity psychiatric conditions. Independent patient's age physician's discipline topical corticosteroids dominate outpatient treatment However, there considerable heterogeneity between treating physicians. lack clinical trials, systemic frequently prescribed In contrast, cyclosporine only plays minor role although its efficacy well-documented trials. This observation stimulated head-to-head trial that indicated superiority over prednisolone adult The control has high priority from perspective general population patients' perspective. Competence physician, disease severity competence to adjust activity main determinants patient satisfaction. Aiming better comparability trials translation evidence into practice, we conducted Delphi exercise including experts 11 countries, editors dermatological journals, regulatory agencies, representatives. preliminary set domains as defined by panel included symptoms, physician-assessed signs, measurement long-term flares. Symptoms such itching should be regularly assessed practice. presented studies indicate not describes analyzes effectiveness but also translational it may stimulate generate new, hypotheses experimental studies.